1. CD34+ cell therapy significantly reduces adverse cardiac events, health care expenditures, and mortality in patients with refractory angina. (12th June 2020) Authors: Johnson, Grace L.; Henry, Timothy D.; Povsic, Thomas J.; Losordo, Douglas W.; Garberich, Ross F.; Stanberry, Larissa I.; Strauss, Craig E.; Traverse, Jay H. Journal: Stem cells translational medicine Issue: Volume 9:Number 10(2020) Page Start: 1147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗